Castleman disease

Research output: Chapter in Book/Report/Conference proceedingChapter

16 Citations (Scopus)

Abstract

Castleman's disease (CD) was first described in 1954 and further defined in 1956 by Dr. Castleman (1) (Figure 13.1). He reported on patients possessing localized mediastinal lymph node enlargement that was characterized by redundancy of lymphoid follicles with germinal-center involution as well as marked capillary proliferation with endothelial hyperplasia in both follicular and interfollicular regions. Prior cases had been reported, but were anecdotal in nature (2, 3). In 1962, Lattes and Pachter evaluated 12 cases and suggested that these lymph nodes were hamartomatous in nature (4). Lee described refractory anemia associated with CD that responded to surgical resection 5, and by 1967, Tung and McCormack described 5 new cases and reviewed the 62 cases described to that point in the literature (6), highlighting the potential for associated hypochromic anemia, hypergammaglobulinemia, and bone marrow plasmacytosis.

Original languageEnglish (US)
Title of host publicationRare Hematological Malignancies
PublisherSpringer US
Pages293-330
Number of pages38
ISBN (Print)9780387737430
DOIs
StatePublished - 2008

Fingerprint

Giant Lymph Node Hyperplasia
Aleurites
Lymph Nodes
Refractory Anemia
Hypochromic Anemia
Hypergammaglobulinemia
Germinal Center
Hyperplasia
Bone Marrow

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dispenzieri, A. (2008). Castleman disease. In Rare Hematological Malignancies (pp. 293-330). Springer US. https://doi.org/10.1007/978-0-387-73744-7_13

Castleman disease. / Dispenzieri, Angela.

Rare Hematological Malignancies. Springer US, 2008. p. 293-330.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dispenzieri, A 2008, Castleman disease. in Rare Hematological Malignancies. Springer US, pp. 293-330. https://doi.org/10.1007/978-0-387-73744-7_13
Dispenzieri A. Castleman disease. In Rare Hematological Malignancies. Springer US. 2008. p. 293-330 https://doi.org/10.1007/978-0-387-73744-7_13
Dispenzieri, Angela. / Castleman disease. Rare Hematological Malignancies. Springer US, 2008. pp. 293-330
@inbook{1284d09ea56f48b0a55ed824e13914e6,
title = "Castleman disease",
abstract = "Castleman's disease (CD) was first described in 1954 and further defined in 1956 by Dr. Castleman (1) (Figure 13.1). He reported on patients possessing localized mediastinal lymph node enlargement that was characterized by redundancy of lymphoid follicles with germinal-center involution as well as marked capillary proliferation with endothelial hyperplasia in both follicular and interfollicular regions. Prior cases had been reported, but were anecdotal in nature (2, 3). In 1962, Lattes and Pachter evaluated 12 cases and suggested that these lymph nodes were hamartomatous in nature (4). Lee described refractory anemia associated with CD that responded to surgical resection 5, and by 1967, Tung and McCormack described 5 new cases and reviewed the 62 cases described to that point in the literature (6), highlighting the potential for associated hypochromic anemia, hypergammaglobulinemia, and bone marrow plasmacytosis.",
author = "Angela Dispenzieri",
year = "2008",
doi = "10.1007/978-0-387-73744-7_13",
language = "English (US)",
isbn = "9780387737430",
pages = "293--330",
booktitle = "Rare Hematological Malignancies",
publisher = "Springer US",

}

TY - CHAP

T1 - Castleman disease

AU - Dispenzieri, Angela

PY - 2008

Y1 - 2008

N2 - Castleman's disease (CD) was first described in 1954 and further defined in 1956 by Dr. Castleman (1) (Figure 13.1). He reported on patients possessing localized mediastinal lymph node enlargement that was characterized by redundancy of lymphoid follicles with germinal-center involution as well as marked capillary proliferation with endothelial hyperplasia in both follicular and interfollicular regions. Prior cases had been reported, but were anecdotal in nature (2, 3). In 1962, Lattes and Pachter evaluated 12 cases and suggested that these lymph nodes were hamartomatous in nature (4). Lee described refractory anemia associated with CD that responded to surgical resection 5, and by 1967, Tung and McCormack described 5 new cases and reviewed the 62 cases described to that point in the literature (6), highlighting the potential for associated hypochromic anemia, hypergammaglobulinemia, and bone marrow plasmacytosis.

AB - Castleman's disease (CD) was first described in 1954 and further defined in 1956 by Dr. Castleman (1) (Figure 13.1). He reported on patients possessing localized mediastinal lymph node enlargement that was characterized by redundancy of lymphoid follicles with germinal-center involution as well as marked capillary proliferation with endothelial hyperplasia in both follicular and interfollicular regions. Prior cases had been reported, but were anecdotal in nature (2, 3). In 1962, Lattes and Pachter evaluated 12 cases and suggested that these lymph nodes were hamartomatous in nature (4). Lee described refractory anemia associated with CD that responded to surgical resection 5, and by 1967, Tung and McCormack described 5 new cases and reviewed the 62 cases described to that point in the literature (6), highlighting the potential for associated hypochromic anemia, hypergammaglobulinemia, and bone marrow plasmacytosis.

UR - http://www.scopus.com/inward/record.url?scp=80755182480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80755182480&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-73744-7_13

DO - 10.1007/978-0-387-73744-7_13

M3 - Chapter

AN - SCOPUS:80755182480

SN - 9780387737430

SP - 293

EP - 330

BT - Rare Hematological Malignancies

PB - Springer US

ER -